Concepedia
Statistics
Publications
21
Citations
2.1K
H-Index
19
Active since
1981
Affiliations
Stanford University(Current)
Ardelyx (United States)
Neurological Surgery
Washington University in St. Louis
University of Oslo
Matthew Siegel is an author at Stanford University specializing in medicine, autoimmunity, and biochemistry.
Top concepts
MedicinePathologyAutoimmunityBiochemistryCell BiologyAutoimmune DiseaseImmunologyAllergyNutritionNatural Sciences
Publications per year
1981–2024
Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Patients With Celiac Sprue
Jonathan Gass, Michael T. Bethune, Matthew Siegel et al. · Gastroenterology · 2007 · 234 citations · Full text
Nutrition, Food Intolerance, Dietary Gluten +6
Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue Injury
Matthew Siegel, Pavel Strnad, Richard E. Watts et al. · PLoS ONE · 2008 · 200 citations · Full text
Immunology, Immune Regulation, Cell Death +21
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy
Matthew Siegel, Kihang Choi, Chaitan Khosla et al. · Oncogene · 2006 · 170 citations
Neuro-oncology, Glioma, Medicine +9
Development and Characterization of a Human and Mouse Intestinal Epithelial Cell Monolayer Platform
Kenji Kozuka, Ying He, Samantha Koo-McCoy et al. · Stem Cell Reports · 2017 · 168 citations · Full text
Chemistry and Biology of Dihydroisoxazole Derivatives: Selective Inhibitors of Human Transglutaminase 2
Kihang Choi, Matthew Siegel, Justin L. Piper et al. · Chemistry & Biology · 2005 · 164 citations · Full text
Human Transglutaminase 2, Molecular Pharmacology, Medicinal Chemistry +12
1–5 of 21